Mesenchymal stem cells from sternum : the type of heart disease, ischemic or valvular, does not influence the cell culture establishment and growth kinetics
Autor(a) principal: | |
---|---|
Data de Publicação: | 2017 |
Outros Autores: | , , , , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Institucional da UFRGS |
Texto Completo: | http://hdl.handle.net/10183/170614 |
Resumo: | Background: In an attempt to increase the therapeutic potential for myocardial regeneration, there is a quest for new cell sources and types for cell therapy protocols. The pathophysiology of heart diseases may affect cellular characteristics and therapeutic results. Methods: To study the proliferative and differentiation potential of mesenchymal stem cells (MSC), isolated from bone marrow (BM) of sternum, we made a comparative analysis between samples of patients with ischemic (IHD) or non-ischemic valvular (VHD) heart diseases. We included patients with IHD (n = 42) or VHD (n = 20), with average age of 60 years and no differences in cardiovascular risk factors. BM samples were collected (16.4 ± 6 mL) and submitted to centrifugation with Ficoll-Paque, yielding 4.5 ± 1.5 × 107 cells/mL. Results: Morphology, immunophenotype and differentiation ability had proven that the cultivated sternal BM cells had MSC features. The colony forming unit-fibroblast (CFU-F) frequency was similar between groups (p = 0.510), but VHD samples showed positive correlation to plated cells vs. CFU-F number (r = 0.499, p = 0.049). The MSC culture was established in 29% of collected samples, achieved passage 9, without significant difference in expansion kinetics between groups (p > 0.05). Dyslipidemia and the use of statins was associated with culture establishment for IHD patients (p = 0.049 and p = 0.006, respectively). Conclusions: Together, these results show that the sternum bone can be used as a source for MSC isolation, and that ischemic or valvular diseases do not influence the cellular yield, culture establishment or in vitro growth kinetics. |
id |
UFRGS-2_19e26f05037cd81b458da3a6daa86900 |
---|---|
oai_identifier_str |
oai:www.lume.ufrgs.br:10183/170614 |
network_acronym_str |
UFRGS-2 |
network_name_str |
Repositório Institucional da UFRGS |
repository_id_str |
|
spelling |
Dias, Lucinara DaddaCasali, Karina RabelloGhem, CarineSilva, Melissa Kristocheck daSausen, GrasielePalma, Patricia Vianna BoniniCovas, Dimas T.Kalil, Renato Abdala KaramSchaan, Beatriz D'AgordNardi, Nance BeyerMarkoski, Melissa Medeiros2017-11-28T02:29:17Z20171479-5876http://hdl.handle.net/10183/170614001053379Background: In an attempt to increase the therapeutic potential for myocardial regeneration, there is a quest for new cell sources and types for cell therapy protocols. The pathophysiology of heart diseases may affect cellular characteristics and therapeutic results. Methods: To study the proliferative and differentiation potential of mesenchymal stem cells (MSC), isolated from bone marrow (BM) of sternum, we made a comparative analysis between samples of patients with ischemic (IHD) or non-ischemic valvular (VHD) heart diseases. We included patients with IHD (n = 42) or VHD (n = 20), with average age of 60 years and no differences in cardiovascular risk factors. BM samples were collected (16.4 ± 6 mL) and submitted to centrifugation with Ficoll-Paque, yielding 4.5 ± 1.5 × 107 cells/mL. Results: Morphology, immunophenotype and differentiation ability had proven that the cultivated sternal BM cells had MSC features. The colony forming unit-fibroblast (CFU-F) frequency was similar between groups (p = 0.510), but VHD samples showed positive correlation to plated cells vs. CFU-F number (r = 0.499, p = 0.049). The MSC culture was established in 29% of collected samples, achieved passage 9, without significant difference in expansion kinetics between groups (p > 0.05). Dyslipidemia and the use of statins was associated with culture establishment for IHD patients (p = 0.049 and p = 0.006, respectively). Conclusions: Together, these results show that the sternum bone can be used as a source for MSC isolation, and that ischemic or valvular diseases do not influence the cellular yield, culture establishment or in vitro growth kinetics.application/pdfengJournal of translational medicine. London. Vol. 15 (May 2017), 161, 11 p.Doenças cardiovascularesDiabetes mellitusMortalidadeMSC establishmentStem cells cultureCell therapyValvular heart diseaseIschemic heart diseaseMesenchymal stem cells from sternum : the type of heart disease, ischemic or valvular, does not influence the cell culture establishment and growth kineticsEstrangeiroinfo:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UFRGSinstname:Universidade Federal do Rio Grande do Sul (UFRGS)instacron:UFRGSORIGINAL001053379.pdf001053379.pdfTexto completo (inglês)application/pdf1709723http://www.lume.ufrgs.br/bitstream/10183/170614/1/001053379.pdf62ae4804ebd8c9b8772ad056e183820eMD51TEXT001053379.pdf.txt001053379.pdf.txtExtracted Texttext/plain42911http://www.lume.ufrgs.br/bitstream/10183/170614/2/001053379.pdf.txtd18aad0ade1df4b0f82e2b99e0529736MD5210183/1706142022-09-24 05:00:13.166578oai:www.lume.ufrgs.br:10183/170614Repositório de PublicaçõesPUBhttps://lume.ufrgs.br/oai/requestopendoar:2022-09-24T08:00:13Repositório Institucional da UFRGS - Universidade Federal do Rio Grande do Sul (UFRGS)false |
dc.title.pt_BR.fl_str_mv |
Mesenchymal stem cells from sternum : the type of heart disease, ischemic or valvular, does not influence the cell culture establishment and growth kinetics |
title |
Mesenchymal stem cells from sternum : the type of heart disease, ischemic or valvular, does not influence the cell culture establishment and growth kinetics |
spellingShingle |
Mesenchymal stem cells from sternum : the type of heart disease, ischemic or valvular, does not influence the cell culture establishment and growth kinetics Dias, Lucinara Dadda Doenças cardiovasculares Diabetes mellitus Mortalidade MSC establishment Stem cells culture Cell therapy Valvular heart disease Ischemic heart disease |
title_short |
Mesenchymal stem cells from sternum : the type of heart disease, ischemic or valvular, does not influence the cell culture establishment and growth kinetics |
title_full |
Mesenchymal stem cells from sternum : the type of heart disease, ischemic or valvular, does not influence the cell culture establishment and growth kinetics |
title_fullStr |
Mesenchymal stem cells from sternum : the type of heart disease, ischemic or valvular, does not influence the cell culture establishment and growth kinetics |
title_full_unstemmed |
Mesenchymal stem cells from sternum : the type of heart disease, ischemic or valvular, does not influence the cell culture establishment and growth kinetics |
title_sort |
Mesenchymal stem cells from sternum : the type of heart disease, ischemic or valvular, does not influence the cell culture establishment and growth kinetics |
author |
Dias, Lucinara Dadda |
author_facet |
Dias, Lucinara Dadda Casali, Karina Rabello Ghem, Carine Silva, Melissa Kristocheck da Sausen, Grasiele Palma, Patricia Vianna Bonini Covas, Dimas T. Kalil, Renato Abdala Karam Schaan, Beatriz D'Agord Nardi, Nance Beyer Markoski, Melissa Medeiros |
author_role |
author |
author2 |
Casali, Karina Rabello Ghem, Carine Silva, Melissa Kristocheck da Sausen, Grasiele Palma, Patricia Vianna Bonini Covas, Dimas T. Kalil, Renato Abdala Karam Schaan, Beatriz D'Agord Nardi, Nance Beyer Markoski, Melissa Medeiros |
author2_role |
author author author author author author author author author author |
dc.contributor.author.fl_str_mv |
Dias, Lucinara Dadda Casali, Karina Rabello Ghem, Carine Silva, Melissa Kristocheck da Sausen, Grasiele Palma, Patricia Vianna Bonini Covas, Dimas T. Kalil, Renato Abdala Karam Schaan, Beatriz D'Agord Nardi, Nance Beyer Markoski, Melissa Medeiros |
dc.subject.por.fl_str_mv |
Doenças cardiovasculares Diabetes mellitus Mortalidade |
topic |
Doenças cardiovasculares Diabetes mellitus Mortalidade MSC establishment Stem cells culture Cell therapy Valvular heart disease Ischemic heart disease |
dc.subject.eng.fl_str_mv |
MSC establishment Stem cells culture Cell therapy Valvular heart disease Ischemic heart disease |
description |
Background: In an attempt to increase the therapeutic potential for myocardial regeneration, there is a quest for new cell sources and types for cell therapy protocols. The pathophysiology of heart diseases may affect cellular characteristics and therapeutic results. Methods: To study the proliferative and differentiation potential of mesenchymal stem cells (MSC), isolated from bone marrow (BM) of sternum, we made a comparative analysis between samples of patients with ischemic (IHD) or non-ischemic valvular (VHD) heart diseases. We included patients with IHD (n = 42) or VHD (n = 20), with average age of 60 years and no differences in cardiovascular risk factors. BM samples were collected (16.4 ± 6 mL) and submitted to centrifugation with Ficoll-Paque, yielding 4.5 ± 1.5 × 107 cells/mL. Results: Morphology, immunophenotype and differentiation ability had proven that the cultivated sternal BM cells had MSC features. The colony forming unit-fibroblast (CFU-F) frequency was similar between groups (p = 0.510), but VHD samples showed positive correlation to plated cells vs. CFU-F number (r = 0.499, p = 0.049). The MSC culture was established in 29% of collected samples, achieved passage 9, without significant difference in expansion kinetics between groups (p > 0.05). Dyslipidemia and the use of statins was associated with culture establishment for IHD patients (p = 0.049 and p = 0.006, respectively). Conclusions: Together, these results show that the sternum bone can be used as a source for MSC isolation, and that ischemic or valvular diseases do not influence the cellular yield, culture establishment or in vitro growth kinetics. |
publishDate |
2017 |
dc.date.accessioned.fl_str_mv |
2017-11-28T02:29:17Z |
dc.date.issued.fl_str_mv |
2017 |
dc.type.driver.fl_str_mv |
Estrangeiro info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://hdl.handle.net/10183/170614 |
dc.identifier.issn.pt_BR.fl_str_mv |
1479-5876 |
dc.identifier.nrb.pt_BR.fl_str_mv |
001053379 |
identifier_str_mv |
1479-5876 001053379 |
url |
http://hdl.handle.net/10183/170614 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.ispartof.pt_BR.fl_str_mv |
Journal of translational medicine. London. Vol. 15 (May 2017), 161, 11 p. |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.source.none.fl_str_mv |
reponame:Repositório Institucional da UFRGS instname:Universidade Federal do Rio Grande do Sul (UFRGS) instacron:UFRGS |
instname_str |
Universidade Federal do Rio Grande do Sul (UFRGS) |
instacron_str |
UFRGS |
institution |
UFRGS |
reponame_str |
Repositório Institucional da UFRGS |
collection |
Repositório Institucional da UFRGS |
bitstream.url.fl_str_mv |
http://www.lume.ufrgs.br/bitstream/10183/170614/1/001053379.pdf http://www.lume.ufrgs.br/bitstream/10183/170614/2/001053379.pdf.txt |
bitstream.checksum.fl_str_mv |
62ae4804ebd8c9b8772ad056e183820e d18aad0ade1df4b0f82e2b99e0529736 |
bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 |
repository.name.fl_str_mv |
Repositório Institucional da UFRGS - Universidade Federal do Rio Grande do Sul (UFRGS) |
repository.mail.fl_str_mv |
|
_version_ |
1815447649296318464 |